Drug Class
ALK inhibitor
Type
ingredient
Active Ingredient
alectinib
📋Overview
Alectinib is a targeted therapy drug classified as an ALK inhibitor. It is primarily associated with the treatment of certain types of non-small cell lung cancer (NSCLC) that have specific genetic alterations. By blocking the activity of the abnormal ALK protein, alectinib helps slow the growth and spread of cancer cells. This medication is often considered when genetic testing reveals the presence of ALK gene rearrangements.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Alectinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.